adenosine A3 antagonists (Addex)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameadenosine A3 antagonists (Addex)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A3 receptor antagonists
TargetsAdenosine A3 receptor
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A